All News
Filter News
Found 806,114 articles
-
Vial Has Added NEXT Oncology, a Global Network of Phase I Cancer Research Centers, to their Preferred Site Network
11/21/2022
Vial has added NEXT Oncology to their Preferred Site Network (PSN).
-
Harpoon Therapeutics to Participate in the Piper Sandler 34th Annual Healthcare Conference
11/21/2022
Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing novel T cell engagers, today announced that management will participate in a fireside chat at the Piper Sandler 34th Annual Healthcare Conference.
-
AnaptysBio to Participate at the Piper Sandler 34th Annual Healthcare Conference
11/21/2022
AnaptysBio, Inc. (Nasdaq: ANAB) today announced that Dan Faga, interim chief executive officer of AnaptysBio, will represent the company in a fireside chat at the Piper Sandler 34th Annual Healthcare Conference on Tuesday November 29th, 2022, at 8:10 a.m. ET / 5:10 a.m. PT.
-
Positive New Research Presented at RSNA 2022 Reaffirms iCAD’s Breast AI Suite Improves Radiologists’ Performance and Breast Cancer Detection
11/21/2022
iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced new and real-world research demonstrating the value of its Breast AI Suite will be highlighted at the Radiological Society of North America (RSNA) Annual Meeting in Chicago, November 27 to December 1.
-
Progress in Emerging Alzheimer's Therapeutics Based on Biology of Aging to be Highlighted in Session Moderated by Alzheimer's Drug Discovery Foundation (ADDF) at 2022 Clinical Trials on Alzheimer's Disease Conference
11/21/2022
The Alzheimer's Drug Discovery Foundation will be moderating a session, "Beyond Amyloid and Tau: Emerging Solutions," at the 2022 Clinical Trials on Alzheimer's Disease (CTAD) conference, which will be held November 29th through December 2nd at the Hilton Union Square in San Francisco, California.
-
BiondVax CEO to Present at the January 2023 Biotech Showcase in San Francisco
11/21/2022
BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) ("BiondVax"), a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, announced today that its CEO Amir Reichman will present at the January 9-11, 2023 Biotech Showcase conference.
-
Aridis Pharmaceuticals Announces Third Quarter 2022 Financial Results and Business Update
11/21/2022
Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies for treating life-threatening infections, today reported financial and corporate results for its third quarter ended September 30, 2022.
-
ERYTECH Provides Business and Financial Update for the Third Quarter of 2022
11/21/2022
ERYTECH Pharma (Nasdaq & Euronext: ERYP),aclinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today provided a business and financial updatefor the third quarter of2022.
-
Diagnostic Imaging Services Market Revenue to Surpass USD 545.7 BN by 2030
11/21/2022
According to Nova one advisor, the global Diagnostic Imaging Services market size is expected to hit around USD 545.7 billion by 2030 from valued at USD 364.2 billion in 2022 and growing at a CAGR of 5.10% from 2022 to 2030.
-
Benign Prostatic Hyperplasia Treatment Market Size to Gain USD 12.9 BN by 2030
11/21/2022
According to Nova one advisor, the global Benign Prostatic Hyperplasia Treatment market was valued at USD 6.48 billion in 2021 and it is expected to hit around USD 12.9 billion by 2030 with a CAGR of 5.68% during the forecast period 2022 to 2030.
-
DNA And Gene Cloning Services Market Revenue to Surpass USD 11.5 BN by 2030
11/21/2022
According to Nova one advisor, the global DNA and Gene Cloning Services market was valued at USD 4.5 billion in 2021 and it is expected to hit around USD 11.5 billion by 2030 with a CAGR of 13.7% during the forecast period 2022 to 2030
-
In Vitro Diagnostics Market Revenue to Surpass USD 113.45 BN by 2030
11/21/2022
The global In Vitro Diagnostics market size was estimated at USD 111.68 billion in 2021 and is expected to surpass around USD 113.45 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 0.3% during the forecast period 2022 to 2030.
-
Life Science Instrumentation Market Size to Gain USD 106.5 BN by 2030
11/21/2022
According to Nova one advisor's recent analyses the global Life Science Instrumentation market size is expected to hit USD 106.5 billion by 2030 from at USD 57.6 billion in 2022 and is expanding growth at a noteworthy CAGR of 6.27% from 2022 to 2030.
-
AI-Based Clinical Trial Solutions For Patient Matching Market on Hit USD 1.90 Bn, Globally, by 2030 at 27.7% CAGR
11/21/2022
According to Nova one advisor, the global AI-based Clinical Trial Solutions For Patient Matching market size is expected to hit around USD 1.90 billion by 2030 from valued at USD 360.9 million in 2022 and growing at a CAGR of 27.7% from 2022 to 2030.
-
Isothermal Nucleic Acid Amplification Technology Market Size to Gain USD 11.9 BN by 2030
11/21/2022
According to Nova one advisor, the global Isothermal Nucleic Acid Amplification Technology market was valued at USD 4.98 billion in 2022 and it is expected to hit around USD 11.9 billion by 2030 with a CAGR of 13.4% during the forecast period 2022 to 2030.
-
U.S. Medical Device Outsourcing Market Revenue to Surpass USD 59.8 BN by 2030
11/21/2022
According to Latest Study, the U.S. Medical Device Outsourcing market size is expected to hit around USD 59.8 billion by 2030 from valued at USD 23.3 billion in 2021 and growing at a CAGR of 11.4% from 2022 to 2030.
-
Clinical Laboratory Services Market Size 2022 to 2030 - Quantitative Research by QYResearch Medical
11/21/2022
The global Clinical laboratory services market was valued at USD 222.51 billion in 2019 and is expected to reach USD 359.38 billion by the year 2030, at a CAGR of 6.1%.
-
Cell Signaling Market Size - Quantitative Research By QYResearch Medical
11/21/2022
The global cell signaling market size was significantly robust in 2020 and is expected to register a steady revenue CAGR over the forecast period.
-
Gene Synthesis Market Size up to 2030 - Quantitative Research by QYResearch Medical
11/21/2022
The rising investments in gene synthesis is among the chief factors that is expected to fuel the growth of the global gene synthesis market.
-
Digital Biology Market Size 2022 to 2030 - Quantitative Research by QYResearch Medical
11/21/2022
Digital biology involves studying the fundamental computation of various biological processes, including gene regulatory systems and neural networks.